Colombia announced the approval of the of Benznidazole 100 mg tablets for timely treatment of Chagas disease and the prevention of serious complications, especially in vulnerable populations and territories at risk.
The decision marks a step forward in public health, facilitating early treatment of affected individuals, reducing the progression of the disease, and helping to prevent chronic complications, mainly cardiac and digestive, associated with this parasitic infection.
“ Timely access to this medication allows us to act promptly, prevent serious complications, and protect the lives of thousands of people, especially in the most vulnerable regions of the country. This is an important step toward closing health gaps and advancing the control of Chagas disease in Colombia ,” stated the Minister of…